About: Drug-induced torsade de pointes: the perspectives of industry

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Drug-induced torsade de pointes: the perspectives of industry Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/oup/periodical/ehjsupp/2001/volume_3/issue_supplk/w
Subject	Articles ‘Points to consider’ QT interval measurements
Title	Drug-induced torsade de pointes: the perspectives of industry
has manifestation of work	http://hub.abes.fr/oup/periodical/ehjsupp/2001/volume_3/issue_supplk/101016s1520765x0190015x/m/print http://hub.abes.fr/oup/periodical/ehjsupp/2001/volume_3/issue_supplk/101016s1520765x0190015x/m/web
related by	http://hub.abes.fr/oup/periodical/ehjsupp/2001/volume_3/issue_supplk/101016s1520765x0190015x/authorship/1
Author	Barbey J.T.
Abstract	In 1996 the Committee for Proprietary Medicinal Products published their ‘Points to consider’ which have been used as unofficial guidelines by drug companies developing new pharmacologic compounds. Recommendaitons endorsed by the CPMP regarding hand measurement of the QT interval, QT dispersion, the Bazett QT interval correction for heart rate and the use of signal values for QTc changes compared to baseline are discussed in this paper.
article type	research-article
is part of this journal	European Heart Journal Supplements

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata